Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

How our clients use DrugPatentWatch

Generated: May 26, 2017

DrugPatentWatch Database Preview

Fluphenazine decanoate - Generic Drug Details

« Back to Dashboard

What are the generic drug sources for fluphenazine decanoate and what is the scope of fluphenazine decanoate freedom to operate?

Fluphenazine decanoate
is the generic ingredient in two branded drugs marketed by Fresenius Kabi Usa, Mylan Labs Ltd, Bristol Myers Squibb, West-ward Pharms Int, Par Sterile Products, Hospira, and Teva Parenteral, and is included in seven NDAs. There is one patent protecting this compound. Additional information is available in the individual branded drug profile pages.

There are eighteen drug master file entries for fluphenazine decanoate. Four suppliers are listed for this compound.

Summary for Generic Name: fluphenazine decanoate

Drug Master File Entries: see list18
Suppliers / Packagers: see list4
Bulk Api Vendors: see list17
Clinical Trials: see list4
Patent Applications: see list1,523
Therapeutic Class:Antipsychotics
Formulation / Manufacturing:see details
Drug Prices:see low prices
DailyMed Link:fluphenazine decanoate at DailyMed

Pharmacology for Ingredient: fluphenazine decanoate

Drug ClassPhenothiazine
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
West-ward Pharms Int
fluphenazine decanoate
INJECTABLE;INJECTION074531-001Aug 30, 1996AORXNoNo► Subscribe► Subscribe
Par Sterile Products
fluphenazine decanoate
INJECTABLE;INJECTION203732-001Jul 3, 2014AORXNoNo► Subscribe► Subscribe
Fresenius Kabi Usa
fluphenazine decanoate
INJECTABLE;INJECTION071413-001Jul 14, 1987AORXNoYes► Subscribe► Subscribe
fluphenazine decanoate
INJECTABLE;INJECTION074966-001Apr 16, 1998DISCNNoNo► Subscribe► Subscribe
Bristol Myers Squibb
fluphenazine decanoate
INJECTABLE;INJECTION016727-001Approved Prior to Jan 1, 1982DISCNYesNo► Subscribe► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Subscribe for Complete Access

  • Anticipate P&T budget requirements
  • Analyze global market entry opportunities
  • Drug patents and clinical trials in dozens of countries

► Plans and Pricing

Expired Orange Book Patents

 Available with subscription

Paragraph IV Activity

 Available with subscription

Patent Maintenance

 Available with subscription

Non-Orange Book Patents

 Available with subscription

International Patents

 Available with subscription

Supplementary Protection Certificates

 Available with subscription

« Back to the Dashboard

For more information try a trial or see the database preview and plans and pricing

How our clients use DrugPatentWatch

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:

Google Plus